Orolevol

Orolevol Brand names, Orolevol Analogs

Orolevol Brand Names Mixture

No information avaliable

Orolevol Chemical_Formula

C₂₀H₂₃NS

Orolevol RX_link

No information avaliable

Orolevol fda sheet

Orolevol msds (material safety sheet)

Orolevol Synthesis Reference

No information avaliable

Orolevol Molecular Weight

309.469 g/mol

Orolevol Melting Point

< 25 ^oC

Orolevol H₂O Solubility

Soluble as HCl salt

Orolevol State

Liquid

Orolevol LogP

5.7

Orolevol Dosage Forms

Tablets (oral, 1 mg)

Orolevol Indication

Used for the symptomatic treatment of parkinsonism.

Orolevol Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Orolevol Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Orolevol side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Orolevol Patient Information

Orolevol Organisms Affected

Humans and other mammals